Status:
COMPLETED
Topical Naloxone to Diagnose Ocular Pain
Lead Sponsor:
Seema Capoor
Conditions:
Dry Eye Syndromes
Neuropathic Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Chronic ocular neuropathic pain may be misdiagnosed as dry eye disease. Our study aims to identify a population with previous monocular trauma and dry eye symptoms and differentiate neuropathic from d...
Detailed Description
Dry eye is a ubiquitous and debilitating ocular condition that affects tens of millions in the United States (DEWS, 2007). However, there is increasing evidence that the symptoms of dry eye overlap wi...
Eligibility Criteria
Inclusion
- monocular trauma
- dry eye disease diagnosis
Exclusion
- any pathology that might contribute to ocular pain, including corneal surface ulcers, uveitis, or other chronic inflammatory processes
- any current corneal surface pathology
- history of bilateral ocular trauma
- currently taking any of the following medications: TCAs, opioids, gabapentin, SNRIs
- pregnant nor breastfeeding.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2020
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04454281
Start Date
October 1 2020
End Date
December 3 2020
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40506